Corazon (Corsee) D. Sanders, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 2,000 shares at $25.05 ($50K) on 2026-06-15, disclosed to the SEC on 2026-06-15.
Seasonal sale ($50k) by Director — this insider has traded RARE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2025-06-23 | $180K | — | Filing → |
| RARE | SELL | 2024-07-03 | $24K | — | Filing → |